How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Travel Medicine Archives

Infection Prevention: The First Line of Defense for Global Health

Prevention Is Where Patient Safety Begins International Infection Prevention Week is more than an annual

October 21, 2026 No Comments

Tracking AMR Through Environmental Wastewater: ISID-Africa Advances Surveillance for Action

The International Society for Infectious Diseases (ISID) and ISID-Africa convened a virtual webinar on 29

October 19, 2026 No Comments

Ebola Bundibugyo Virus Disease in Kenya – Level 1 – Level 1 – Practice Usual Precautions – Travel Health Notices | Travelers’ Health

Bundibugyo virus disease (BVD) is a rare and potentially deadly type of viral hemorrhagic fever. BVD

October 19, 2026 No Comments

Infection Prevention: The First Line of Defense for Global Health

Tracking AMR Through Environmental Wastewater: ISID-Africa Advances Surveillance for Action

Ebola Bundibugyo Virus Disease in Kenya – Level 1 – Level 1 – Practice Usual Precautions – Travel Health Notices | Travelers’ Health

Yellow Fever in Ghana – Level 2 – Level 2 – Practice Enhanced Precautions – Travel Health Notices | Travelers’ Health

ISID Collaborates With Mediaplanet on Future of Healthy Living Campaign

ISID Collaborates With Mediaplanet on Future of Healthy Living Campaign

Hepatitis A in Costa Rica – Level 1 – Level 1 – Practice Usual Precautions – Travel Health Notices | Travelers’ Health

ISID-Africa Brings One Health and AMR Expertise to Strengthen Safe International Trade in Africa

Upcoming ISID Webinar: ISID-Africa | Wastewater and Environmental Surveillance for AMR Control

ISID-Africa Advances One Health AMR Leadership at the ReAct Africa Annual AMR Conference 2026

Schedule an Appointment

Quick Links

Patient Forms

Contact Us